FULCRUM THERAPEUTICS INC (FULC) Stock Balance Sheet
NASDAQ:FULC - Nasdaq - US3596161097 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 58.21M | 25.56M | 35.10M | 35.40M | 57.10M | |||
| Marketable Securities | 182.81M | 210.66M | 167.80M | 182.80M | 55.90M | |||
| Receivables | 3.34M | 2.25M | 1.10M | 4.10M | 2.70M | |||
| Other Current Assets | 5.56M | 3.73M | 3.50M | 3.70M | 3.90M | |||
| Total Current Assets | 249.92M | 242.20M | 207.50M | 226.00M | 119.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 9.58M | 12.39M | 16.00M | 7.40M | 8.40M | |||
| Other Non-Current Assets | 1.21M | 3.10M | 3.20M | 1.60M | 1.70M | |||
| Total Non-Current Assets | 10.80M | 15.50M | 19.20M | 9.00M | 10.10M | |||
| TOTAL ASSETS | 260.72M | 257.69M | 226.70M | 235.00M | 129.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Accrued Expenses | 9.42M | 10.52M | 12.00M | 9.20M | 7.20M | |||
| Accounts Payable | 1.16M | 2.76M | 3.60M | 4.80M | 4.10M | |||
| Other Current Liabilities | 463.00K | 396.00K | 1.00M | 5.30M | 15.40M | |||
| Total Current Liabilities | 11.04M | 13.68M | 16.70M | 19.20M | 26.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 6.64M | 8.83M | 11.00M | 4.30M | 7.70M | |||
| Total Non-Current Liabilities | 6.64M | 8.83M | 11.00M | 4.30M | 7.70M | |||
| TOTAL LIABILITIES | 17.68M | 22.50M | 27.70M | 23.50M | 34.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -519.40M | -509.67M | -412.30M | -302.50M | -221.60M | |||
| Additional Paid In Capital | 762.25M | 744.94M | 612.00M | 514.40M | 316.80M | |||
| Common Shares | 54.00K | 62.00K | 100.00K | 0.00 | 0.00 | |||
| Treasury Stock | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 130.00K | -136.00K | -800.00K | -400.00K | 0.00 | |||
| Shares Outstanding | 53.97M | 61.92M | 52.10M | 40.60M | 27.90M | |||
| Tangible Book Value per Share | 4.50 | 3.80 | 3.82 | 5.21 | 3.41 | |||
| Total Shareholders' Equity | 243.03M | 235.19M | 198.90M | 211.50M | 95.20M | |||
| TOTAL LIABILITIES AND EQUITY | 260.72M | 257.69M | 226.70M | 235.00M | 129.60M | |||
| Statistics | ||||||||
| Current Ratio | 22.63 | 17.71 | 12.43 | 11.77 | 4.48 | |||
| Return On Assets (ROA) | -3.73% | -37.77% | -48.46% | -34.40% | -54.65% | |||
| Return On Equity (ROE) | -4.00% | -41.39% | -55.24% | -38.23% | -74.39% | |||
All data in USD , ROIC based on taxRate of 0.21